Lazard Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19K Sell
3,488
-7,326
-68% -$39.9K ﹤0.01% 2128
2025
Q1
$88K Buy
10,814
+2,439
+29% +$19.8K ﹤0.01% 1839
2024
Q4
$78K Sell
8,375
-131
-2% -$1.22K ﹤0.01% 1876
2024
Q3
$90K Buy
8,506
+8,356
+5,571% +$88.4K ﹤0.01% 1796
2024
Q2
$0 Sell
150
-7,005
-98% ﹤0.01% 2305
2024
Q1
$83K Sell
7,155
-4,312
-38% -$50K ﹤0.01% 1594
2023
Q4
$162K Buy
11,467
+445
+4% +$6.29K ﹤0.01% 1468
2023
Q3
$133K Buy
11,022
+5,322
+93% +$64.2K ﹤0.01% 1525
2023
Q2
$71K Sell
5,700
-9,680
-63% -$121K ﹤0.01% 1707
2023
Q1
$170K Buy
15,380
+1,187
+8% +$13.1K ﹤0.01% 1350
2022
Q4
$173K Buy
14,193
+4,356
+44% +$53.1K ﹤0.01% 1325
2022
Q3
$102K Hold
9,837
﹤0.01% 1470
2022
Q2
$105K Buy
9,837
+3,981
+68% +$42.5K ﹤0.01% 1489
2022
Q1
$55K Hold
5,856
﹤0.01% 1693
2021
Q4
$67K Sell
5,856
-112,559
-95% -$1.29M ﹤0.01% 1609
2021
Q3
$1.13M Buy
+118,415
New +$1.13M ﹤0.01% 1046
2021
Q2
Sell
-5,657
Closed -$55K 1995
2021
Q1
$55K Buy
5,657
+2,763
+95% +$26.9K ﹤0.01% 1394
2020
Q4
$66K Hold
2,894
﹤0.01% 1301
2020
Q3
$40K Sell
2,894
-1,833
-39% -$25.3K ﹤0.01% 1244
2020
Q2
$71K Sell
4,727
-3,259
-41% -$49K ﹤0.01% 1114
2020
Q1
$73K Buy
7,986
+4,338
+119% +$39.7K ﹤0.01% 1066
2019
Q4
$35K Buy
3,648
+2,739
+301% +$26.3K ﹤0.01% 1130
2019
Q3
$7K Buy
+909
New +$7K ﹤0.01% 1335
2019
Q2
Sell
-6,243
Closed -$84K 1210
2019
Q1
$84K Sell
6,243
-9,080
-59% -$122K ﹤0.01% 1045
2018
Q4
$146K Buy
+15,323
New +$146K ﹤0.01% 886
2015
Q3
Sell
-90,355
Closed -$1.28M 1106
2015
Q2
$1.28M Buy
+90,355
New +$1.28M ﹤0.01% 673